The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

11 de mar. de 2019

For over more than two hours, the first edition of the BioInternational Seminars 2019, hosted by the Biotechnology Business Institute, was a success in terms of participation and interaction between the panelist and the audience. “This type of interaction helps young scientific profiles to understand the sector and have a vision in the horizons of drug discovery in lifesciences”, - ensures Juan R. Garcia, Chairman at the Biotechnology Business Institute.

In this first edition of the year, three international professionals with different backgrounds participated as panelists over the evening. Lubor Gaal, Vice-President of Business Development in Europe for Locust Walk, a global lifescience firm helping biopharma and medtech clients with financing and business development transactions; Jordi Naval, Chief Executive Officer  of Biocat, the Catalan BioRegion Foundation, and also Co-founder of Aelix Therapeutics; and François Riva, Director of Business development at MedSir, a company focused on the innovative design and management os strategic clinical trials for, among others, immuno-oncology, one of the most promising therapeutic area for new treatments in oncology nowadays.

Different topics were discussed regarding drug developments and interactions in the global sector and one of the main conclusions was, that the ecosystem in Barcelona is deeply growing and the development of young professionals with an international view and vision is crucial to support the future ecosystem. Different points of view from different backgrounds such the industry, financials, biotechnology companies, governments and innovation clusters, did conclude that the versatility of a scientific profile, with a global understanding of the sector is definitely an enormous add value for their professional development.

Press Release


Next Edition of the BIS 2019, 4th of April at the Scientific Park of Barcelona

Últimas noticias

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filtrar por categoría